eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-GENB-Generate Biomedicines, Inc

Generate Biomedicines, Inc GENB

‎$‎13.680.28(2.09%)(1D)
Delayed prices by NASDAQin USD
Analyst Forecast
Consensus
Strong Buy
Price Target
25.25
Based on analysts who covered GENB
Invest in Generate Biomedicines, Inc
Today
Create an eToro account to buy GENB stock on a secure, user-friendly, multi-asset trading platform.
Generate Biomedicines, Inc GENB
Buy Generate Biomedicines, Inc

GENB Stock Price Chart

‎-22.21‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset positive trend

The Generate Biomedicines, Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Generate Biomedicines, Inc price today is ‎$‎13.68, a ‎2.09‎% change in the last 24 hours and ‎0.59‎% in the past week. Generate Biomedicines, Inc price changed by ‎0‎% in the past year.
GENB Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
-

Day’s Range
i
Shows the high and low prices of the day.
‎$‎13.45 - ‎$‎14.02

52W Range
i
Shows the high and low prices of the last year.
‎$‎11 - ‎$‎18.05

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
-

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-

Revenue
i
The total income generated by this company’s goods and services last year.
-

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
-

Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎13.68

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
-

How can I buy Generate Biomedicines, Inc stocks?

To purchase Generate Biomedicines, Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Generate Biomedicines, Inc (GENB) page and place an order to buy Generate Biomedicines, Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
What Is Leverage and Margin?
What Is Leverage and Margin?
How do leverage and margin work? We explain what leverage is and how investors can use margin and leverage to increase their buying power.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
Invest in Generate Biomedicines, Inc
Today
Create an eToro account to buy GENB stock on a secure, user-friendly, multi-asset trading platform.
Buy Generate Biomedicines, Inc

FAQ

The current price of GENB is ‎$‎13.68.
The average price target for Generate Biomedicines, Inc is ‎$‎25.25. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Generate Biomedicines, Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Generate Biomedicines, Inc is (The data is unavailable right now)
Based on 4 analysts offering recommendations for GENB in the last 3 months, the overall consensus is Strong Buy.
Scroll to top